Enalare Therapeutics
BiopharmaNaples, FL
Total funding$76M#1 of 5 in Biopharma
Founded2019
SectorBiopharma
HQNaples
About
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from acute respiratory and critical care conditions including respiratory depression caused by drug overdose, post-surgery, and pathogens.
Enalare Therapeutics is the only Biopharma company we track in Southwest Florida — one of 5 across Florida.
Similar companies
View allKincell BioBiopharma | Est. 2023 | GNV | $58M |
ADvantage TherapeuticsBiopharma | Est. 2021 | MIA | $21M |
Cadrenal TherapeuticsBiopharma | Est. 2022 | JAX | $20M |
HalodineBiopharma | Est. 2020 | MIA | $2.3M |
TENEX.AIArtificial Intelligence (AI) | Est. 2024 | SWFL | $277M |
Details
- Region
- Southwest Florida
- City
- Naples
- Founded
- 2019
- Sector
- Biopharma
- Founders
- Joseph Pergolizzi
- Website
- enalare.com
Southwest Florida
Southwest Florida — Naples, Fort Myers, and Sarasota — mixes wealth-tech, hurricane-resilient manufacturing, and a fast-growing Gulf Coast founder base.
45companies
$1.1Braised